Palo Alto Investors LP Amicus Therapeutics, Inc. Transaction History

Palo Alto Investors LP

$727 Million
Q3 2024

A detailed history of Palo Alto Investors LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 8,145,311 shares of FOLD stock, worth $78.7 Million. This represents 11.97% of its overall portfolio holdings.

Number of Shares

8,145,311

Previous 9,029,843 9.8%

Holding current value

$78.7 Million

Previous $89.6 Million 2.89%

% of portfolio

11.97%

Previous 11.34%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $8.45 Million - $10.7 Million	-884,532 Reduced 9.8%	8,145,311 $87 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $2.84 Million - $3.69 Million	-314,259 Reduced 3.36%	9,029,843 $89.6 Million
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $11.8 Million - $14.7 Million	-1,029,613 Reduced 9.93%	9,344,102 $110 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $1.5 Million - $2.18 Million	-150,307 Reduced 1.43%	10,373,715 $147 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $330,573 - $410,262	30,300 Added 0.29%	10,524,022 $117 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $6.39 Million - $8.2 Million	645,948 Added 6.56%	10,493,722 $128 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $348,799 - $622,575	-55,987 Reduced 0.57%	9,847,774 $106 Million
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $1.66 Million - $2.62 Million	-210,282 Reduced 2.08%	9,903,761 $93.8 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $975,384 - $1.32 Million	111,600 Added 1.12%	10,114,043 $96.6 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $2.1 Million - $2.59 Million	241,400 Added 2.47%	10,002,443 $96.4 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $17.4 Million - $45.2 Million	1,893,929 Added 24.07%	9,761,043 $96.4 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $6.86 Million - $8.46 Million	532,400 Added 7.26%	7,867,114 $111 Million
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $1 Million - $1.77 Million	-112,904 Reduced 1.52%	7,334,714 $111 Million
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $223,417 - $376,069	33,698 Added 0.45%	7,447,618 $68.8 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $1.88 Million - $2.7 Million	251,000 Added 3.5%	7,413,920 $72.2 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $5.08 Million - $8.39 Million	-633,379 Reduced 8.12%	7,162,920 $57.4 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $1.93 Million - $2.54 Million	176,466 Added 2.32%	7,796,299 $97.3 Million
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $2.19 Million - $3.04 Million	218,512 Added 2.95%	7,619,833 $104 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $8.67 Million - $13.9 Million	1,035,174 Added 16.26%	7,401,321 $70.9 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $2.29 Million - $3.27 Million	197,800 Added 3.21%	6,366,147 $77 Million
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $269,401 - $350,652	20,518 Added 0.33%	6,168,347 $96.4 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $1.95 Million - $2.43 Million	141,807 Added 2.36%	6,147,829 $92.5 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $17.7 Million - $23 Million	-1,414,266 Reduced 19.06%	6,006,022 $86.4 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $87.1 Million - $117 Million	7,420,288	7,420,288 $112 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Account

Palo Alto Investors LP Amicus Therapeutics, Inc. Transaction History